1. Israel Stocks

  2. •

    Finance

  3. •

    Investment managers
Teuza - A Fairchild Technology Venture Ltd.

Teuza - A Fairchild Technology Venture Ltd.

TTASE:TUZA
24.30
ILA
+1.40
(+6.11%)
4.28BMarket Cap
Teuza - A Fairchild Technology Venture Ltd.
TASE:TUZA
(Tel Aviv Stock Exchange)

Recent

price

24.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
0.01
- -
Revenue per Share
-0.02
-0.03
-0.01
- -
-0.01
-0.02
0.01
0.02
-0.02
-0.06
-0.02
-0.03
-0.01
- -
Basic EPS, GAAP
-0.02
-0.01
-0.01
-0.01
-0.01
-0.01
-0.02
-0.01
-0.01
-0.02
-0.01
-0.01
- -
- -
Free Cash Flow per Basic Share
0.02
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.27
0.24
0.24
0.24
0.22
0.23
0.25
0.22
0.17
0.15
0.12
0.11
0.11
Book Value per Share
- -
0.27
0.24
0.24
0.24
0.22
0.23
0.25
0.22
0.17
0.15
0.12
0.11
0.11
Tangible Book Value per Share
98
98
107
114
114
114
114
114
114
114
114
114
114
114
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
- -
1
- -
Sales/Revenue/Turnover
-613.89
-5,057.41
-14,900
5,620
-20,800
-42,420
- -
- -
- -
-279.2
- -
- -
-173.4
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-3
-1
- -
-1
-2
1
2
-3
-7
-2
-3
-1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-617.78
-5,000
-14,900
6,020
-20,000
-42,580
- -
- -
- -
-275.83
- -
- -
-165.96
- -
Profit Margin (%)
- -
6
4
2
3
4
8
9
7
7
5
4
3
3
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
27
27
28
27
25
26
28
25
19
17
14
13
13
Total Equity
- -
- -
- -
1.03
- -
- -
3.78
7.57
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
1.1
- -
- -
4.11
8.11
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-2.78
1.1
-3.66
-8.26
4.11
8.08
-10.15
-29.66
-11.06
-20.72
-9.45
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
114
114
114
Market Capitalization
13
13
14

Working Capital

USD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
4
3
3
Cash, Cash Equivalents & STI
3
3
2
Accounts Receivable, Net
- -
1
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-6.73%
-14.48%
-8.88%
Free Cash Flow
-2.19%
-15.37%
-55.81%
Net Income, GAAP
-65.07%
-30.37%
-60.88%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
1

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.03
2025
- -
- -
-0.01

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Morgan Stanley (NYSE:MS)
BlackRock, Inc. (NYSE:BLK)
Motilal Oswal Financial Services Limited (NSE:MOTILALOFS)
Blackstone Inc. (NYSE:BX)
HDFC Asset Management Co. Ltd. (NSE:HDFCAMC)
360 One Wam Limited (NSE:360ONE)
Business
Teuza - A Fairchild Technology Venture Ltd. (TUZA.TA) is an Israel-based publicly traded venture capital fund that invests in early-stage and growth technology companies, specializing in seed, pre-seed, expansion capital, and mezzanine financing across sectors including software, communications, electronics, information technology, medical equipment, and healthcare; its portfolio features investments in companies such as Nova Measuring Instruments Ltd., Bioness, Sagantec, Qualion, and others, providing strategic support for market entry in regions like the United States, Europe, China, and Japan. Founded in 1992 and headquartered at 49 Hahistadrut Avenue in Haifa, Israel, the firm targets innovative ventures primarily in Israel, with additional focus on companies in China, Canada, and the United States, typically deploying $1 million to $2 million per investment in equity or equity-linked securities. Recent activities include a seed VC investment in Kidas in July 2021 and participation in TytoCare's Series D round in April 2020, alongside ongoing portfolio management amid challenging market conditions reflected in negative net income and ROE of -34.75% as of November 2025.